Finance

Lists
206A:TYO
PRISM BioLab Co Ltd
Â¥171.00
-2.29%
(-4.00) 1D
Sep 2, 2:59:07 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 206A...
Open
Â¥172
High
Â¥173
Low
Â¥167
Mkt. cap
6.33B
Avg. vol.
100.57K
Volume
64.90K
52-wk high
Â¥279
52-wk low
Â¥125
EPS
-Â¥24
No. of employees
35
Open
Â¥172
High
Â¥173
Low
Â¥167
Mkt. cap
6.33B
Avg. vol.
100.57K
Volume
64.90K
52-wk high
Â¥279
52-wk low
Â¥125
EPS
-Â¥24
No. of employees
35
About PRISM BioLab Co Ltd
CEO-
Employees35
FoundedApr 2, 2012
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
368.33M
132.92M
120.08M
116.68M
Cost of goods sold
109.57M
91.80M
80.20M
79.78M
Cost of revenue
109.57M
91.80M
80.20M
79.78M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
279.21M
325.83M
340.17M
281.70M
Operating expense
279.21M
325.83M
340.17M
281.70M
Total operating expenses
388.78M
417.63M
420.37M
361.48M
Operating income
-20.45M
-284.71M
-300.29M
-244.80M
Other non operating income
-2.65M
-304.00K
304.00K
-499.00K
EBT including unusual items
-29.28M
-284.94M
-317.06M
-241.85M
EBT excluding unusual items
-9.30M
-267.43M
-293.57M
-239.49M
Income tax expense
1.42M
605.00K
395.00K
815.00K
Effective tax rate
-
-0.21%
-0.12%
-
Other operating expenses
-
-
-
-
Net income
-30.70M
-285.55M
-317.45M
-242.67M
Net profit margin
-
-214.83%
-264.37%
-
Earnings per share
-
-
-
-
Interest and investment income
3.30M
3.07M
3.93M
4.16M
Interest expense
-
-
-
-
Net interest expenses
3.30M
3.07M
3.93M
4.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps